GlassScriptPhysician profile
Adlai Pappy
NPI 1508326174
$12,838.59
in general payments reported to CMS, 2019-2025
9 companies · $1,523 in 2025
The $1,523 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $302 · 2023: $4,474 · 2024: $6,541 · 2025: $1,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,833 · Food and Beverage: $5,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,832.78 |
| Food and Beverage | $5,704.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,331.59 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $3,794.70 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $680.78 | 2024-2025 | Prospera |
| Stryker Corporation | $307.05 | 2024-2025 | Spinejack, Mild Device Kit |
| Averitas Pharma INC. | $300.57 | 2023-2024 | Qutenza |
| Nevro Corp. | $201.25 | 2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $139.35 | 2024 | Ajovy |
| Si-Bone, INC. | $52.13 | 2024 | |
| Abbvie INC. | $31.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adlai Pappy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.